KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Prepaid Assets: 2010-2024

Historic Prepaid Assets for Pacira BioSciences (PCRX) over the last 15 years, with Dec 2024 value amounting to $21.9 million.

  • Pacira BioSciences' Prepaid Assets rose 83.87% to $43.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.5 million, marking a year-over-year increase of 83.87%. This contributed to the annual value of $21.9 million for FY2024, which is 1.98% up from last year.
  • As of FY2024, Pacira BioSciences' Prepaid Assets stood at $21.9 million, which was up 1.98% from $21.5 million recorded in FY2023.
  • In the past 5 years, Pacira BioSciences' Prepaid Assets registered a high of $21.9 million during FY2024, and its lowest value of $12.3 million during FY2020.
  • Over the past 3 years, Pacira BioSciences' median Prepaid Assets value was $21.5 million (recorded in 2023), while the average stood at $19.6 million.
  • Data for Pacira BioSciences' Prepaid Assets shows a peak YoY skyrocketed of 41.26% (in 2023) over the last 5 years.
  • Pacira BioSciences' Prepaid Assets (Yearly) stood at $12.3 million in 2020, then increased by 20.43% to $14.8 million in 2021, then rose by 3.06% to $15.2 million in 2022, then spiked by 41.26% to $21.5 million in 2023, then grew by 1.98% to $21.9 million in 2024.